11.12.2024 • News

Statement: Arthur Jaunich, CEO, Stockmeier Chemicals

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

The current European economic environment remains challenging, with structural issues—for example, high energy costs, excessive regulation, or scarcity of labor—limiting the competitiveness and growth prospects of many industrial producers. Also, chemical distribution, especially in basic chemicals, is impacted by slowing demand and price erosion. We expect market consolidation to further accelerate in the chemical distribution sector. Still, we at Stockmeier Chemicals, stay optimistic. As a chemical distributor, we support our customers with an efficient, reliable, and safe supply of a broad portfolio of chemicals. We help optimize product sourcing and logistics, provide support related to regulation and sustainability, and offer individual toll manufacturing solutions. At Stockmeier Chemicals we keep investing in our offering of value-added services to best support our customers in building their competitive edge. And we will continue to expand, also M&A driven, to provide both our customers as well as principals with even broader coverage.

Arthur Jaunich, Stockmeier Chemicals © Stockmeier Chemicals
Arthur Jaunich, Stockmeier Chemicals © Stockmeier Chemicals

“At Stockmeier Chemicals we keep investing in our offering of value-added services to best support our customers in building their competitive edge.”

Company

Logo:

STOCKMEIER Holding GmbH

Am Stadtholz 37
33609 Bielefeld
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.